Product Information
CYCLOSPORINE MODIFIED 50 MG is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.7646 per EA under NDC 23155083830. Its NADAC has been published 186 times since Mar 15, 2023.
FDA first approved this application on Aug 2, 2022. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155083830
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CYCLOSPORINEApproval Type
Generic (ANDA)
FDA Application
ANDA216046FDA Approved
8/2/2022
TE Code
AB1
On Market Since
11/30/2022
Pharmacological Classes
Price Statistics
The NADAC for CYCLOSPORINE MODIFIED 50 MG has been published 186 times since Mar 15, 2023, and over the history we have for it it has declined 24.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7646 per EA |
|---|---|
| All-time high | $1.2947 (Feb 14, 2024) |
| All-time low | $0.6456 (Mar 18, 2026) |
| 52-week high | $0.8202 |
| 52-week low | $0.6456 |
| Median price | $0.9956 |
| Average price | $0.9593 |
| Largest weekly change | -36.2% (Nov 20, 2024) |
| Weeks tracked | 186 |
| Tracking since | Mar 15, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CYCLOSPORINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Heritage Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CYCLOSPORINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcineurin Inhibitor Immunosuppressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CYCLOSPORINE MODIFIED 50 MG?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOSPORINE MODIFIED 50 MG, manufactured by Heritage Pharmaceuticals Inc., is $0.7646 per EA (NDC 23155083830), effective Sep 30, 2026.
How has the price of CYCLOSPORINE MODIFIED 50 MG changed over time?
Over the history we have for it, the NADAC for CYCLOSPORINE MODIFIED 50 MG has declined 24.2%. It has been tracked across 186 weekly CMS publications since Mar 15, 2023.
What are the highest and lowest recorded NADAC prices for CYCLOSPORINE MODIFIED 50 MG?
Since Mar 15, 2023, the NADAC for CYCLOSPORINE MODIFIED 50 MG has ranged from a low of $0.6456 (Mar 18, 2026) to a high of $1.2947 (Feb 14, 2024), with a median of $0.9956 per EA.
Are there cheaper alternatives to CYCLOSPORINE MODIFIED 50 MG?
No other NADAC-published product currently shares the active ingredient and strength of CYCLOSPORINE MODIFIED 50 MG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CYCLOSPORINE MODIFIED 50 MG?
CYCLOSPORINE MODIFIED 50 MG (NDC 23155083830) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.